STOCK TITAN

Haleon Stock Price, News & Analysis

HLN NYSE

Welcome to our dedicated page for Haleon news (Ticker: HLN), a resource for investors and traders seeking the latest updates and insights on Haleon stock.

Haleon (HLN), a global leader in consumer health, provides science-backed solutions through trusted brands like Sensodyne and Advil. This page aggregates official announcements and financial updates essential for understanding the company’s strategic direction in oral care, pain relief, and wellness markets.

Access real-time press releases covering earnings reports, product innovations, regulatory milestones, and partnership developments. Investors gain critical insights into HLN’s operational performance while analysts track market positioning within the $1.5 trillion consumer health sector.

Key updates include R&D breakthroughs, sustainability initiatives, and geographic expansions. All content is sourced directly from Haleon’s communications to ensure accuracy and compliance with financial disclosure standards.

Bookmark this page for streamlined access to HLN’s evolving narrative. Combine our verified updates with Stock Titan’s analysis tools for informed decision-making in dynamic healthcare markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
partnership
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
partnership
-
Rhea-AI Summary

Excedrin has launched the Head Care Club, a program designed to support everyday head health with routines from Emmy Award-winning choreographer Derek Hough. Research indicates that 70% of those experiencing migraines report a negative impact on their quality of life. The program promotes a holistic approach, encouraging proactive measures beyond just treating migraine attacks.

The new Head Care product line includes a daily dietary supplement and nutrient mixes aimed at improving head health. It emphasizes the need for mindfulness, nutrition, and movement to manage headaches and migraines effectively. Dr. Deena Kuruvilla, a neurologist, supports these methods, highlighting their potential benefits for overall brain health. Excedrin aims to enhance well-being via small lifestyle adjustments, reflecting its commitment to comprehensive headache management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
Rhea-AI Summary

Haleon plc announced the redemption of its total outstanding $300 million Callable Floating Rate Senior Notes due 2024 by its subsidiary, GSK Consumer Healthcare Capital US LLC. The redemption is set for March 24, 2023, at a price equal to 100% of the principal amount plus any accrued interest. All noteholders will receive a notice of redemption from the trustee, Deutsche Bank Trust Company Americas, and the notes must be surrendered to collect the redemption price. This move underlines Haleon's financial strategy as it manages its debt obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
none
-
Rhea-AI Summary

Haleon plc (LSE: HLN, NYSE: HLN) announced the expiration and final results of its exchange offers for seven series of unregistered notes issued by GSK Consumer Healthcare Capital. The offers, launched on September 29, 2022, expired on October 28, 2022. The Exchange Notes, which have been registered under the Securities Act, will replace the Original Notes. Settlement is expected on November 2, 2022. The primary aim was to provide holders of Original Notes with registered securities, eliminating prior transfer restrictions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
none
-
Rhea-AI Summary

Haleon and Microsoft have partnered to enhance health product accessibility for individuals who are blind or have low vision. Launched on World Sight Day, the collaboration improves the Microsoft Seeing AI app, enabling detailed audio narrations for over 1,500 Haleon products across the U.S. and U.K. Users can scan barcodes to receive crucial information about product name, ingredients, and usage. This initiative aims to empower users in managing their health independently. Haleon also introduced its Health Inclusivity Index, aiming to enhance global health inclusivity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
none
Rhea-AI Summary

Haleon plc (LSE: HLN, NYSE: HLN) announced the start of exchange offers for seven series of outstanding unregistered notes from GSK Consumer Healthcare Capital. The offers aim to exchange these unregistered notes for registered notes under the Securities Act, expected to be listed on the NYSE. The exchange period ends at 5:00 p.m. (Eastern time) on October 28, 2022, with settlement anticipated on November 2, 2022. A registration statement related to the exchange notes was filed with the SEC on the same date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
none

FAQ

What is the current stock price of Haleon (HLN)?

The current stock price of Haleon (HLN) is $10.7 as of May 2, 2025.

What is the market cap of Haleon (HLN)?

The market cap of Haleon (HLN) is approximately 45.9B.
Haleon

NYSE:HLN

HLN Rankings

HLN Stock Data

45.89B
4.51B
0.02%
11.99%
0.59%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge